Full Details About Innova Captab Limited IPO


  • Establishment: 📅 Established in 2006, Innova Captab Limited has rapidly ascended the ranks of the Indian pharmaceutical sector.
  • Comprehensive Presence: 🌐 A comprehensive presence across R&D, manufacturing, distribution, marketing, and exports underscores its integrated approach.
  • Clientele: 🏢 Proudly serving all of the top 10 and 14 of the top 15 Indian pharmaceutical companies, Innova Captab Limited has become a cornerstone in the industry.
  • Manufacturing Facilities: 🏭 Boasting two cutting-edge manufacturing facilities, the company maintains global quality standards, including WHO-GMP and EU-GMP certifications.
  • R&D Contribution: 🧪 The in-house R&D unit is a driving force behind an expanding product portfolio, contributing to customer retention and industry competitiveness.
  • Dedicated Workforce: 👥 With over 1000 dedicated employees, the company embodies a commitment to innovation and growth.
  • Corporate Responsibility: 🌱 Innova Captab Limited sets a high bar for corporate responsibility, adhering to ESG compliance in legal, ethical, and environmental realms.

Innova Captab Limited IPO details

Key Details

Information about Innova Captab Limited IPO presented in bullet points:

  • Issue Size: 💰 ₹750 Cr (Fresh issue: Up to ₹320 Cr, Offer for sale: Up to ₹250 Cr)
  • Type: 📚 Book built issue
  • Subscription Period: 🗓️ 21-Dec-2023 to 26-Dec-2023
  • Allotment Date: 📅 27 Dec 2023
  • Initiation of Refunds: 💸 28 Dec 2023
  • Listing Date: 📈 29 Dec 2023
  • Price Band: 💹 ₹426 to ₹448 per share
  • Minimum Lot Size: 📊 33 shares
  • Retail Investor Minimum Investment: 💵 ₹14,784
  • sNII (Non-Institutional Investors) Minimum Lot Size: 🤝 14 lots (462 shares), amounting to ₹206,976
  • bNII (Non-Institutional Investors) Minimum Lot Size: 🤝 68 lots (2,244 shares), amounting to ₹1,005,312
IPO Date21 Dec 23 – 26 Dec 23
Issue Size₹570 Cr (Initial Public Offer of Fresh issue size Up to ₹320 Cr and Offer for sale up to ₹250 Cr)
Lot Size33 shares
Price Range₹426 to ₹448 per share
Face Value ₹10 per share
Issue Type100% book building
Cut-off time for UPI Mandate Confirmation26-Dec-2023 (upto 5:00 PM) The new cut-off time for UPI mandate acceptance is 05:00 PM on last day of IPO bidding.

Lot Size

Retail (max)13429₹192,192
Small HNI (min)14462₹206,976
Small HNI (max)672,211₹990,528
Big HNI (min)682,244₹1,005,312

Important Dates

Innova Captab Limited IPO opens on 21 Dec 23 and closes on 26 Dec 23

IPO opening date21 Dec 23, Tuesday (10:00 AM)
IPO closing date26 Dec 23, Thursday (05:00 PM)
Basis of allotment27 Dec 23, Friday
Initiation of Refunds28 Dec 23, Tuesday
Credit of Shares to Demat28 Dec 23, Tuesday
Listing Date29 Dec 23, Wednesday

Company Financial Report

Total AssetsTotal RevenueProfit After Tax
31 Mar 23704.41935.5867.95
31 Mar 22575.48803.4163.95
31 Mar 21369.62412.0334.50
amount in Crores (₹)

Key Performance Indicators (KPIs)

Price to Earning (P/E)31.64
Return on capital employed(ROCE)22.61%
Return on Equity (ROE)24.58%
Avergage Return On Networth (RoNW)21.12%
Earning Per Share (EPS)14.12
Debt to Equity0.85

The source of the information provided is NSE. We do not guarantee the correctness of facts and information. It is provided as it available on NSE.

Competitor Analysis

CompanyMarket Cap(in Crores)PEROE(%)ROCE(%)
Innova Captab
Torrent Pharmaceuticals Ltd₹ 73,47254.72019.8
Laurus Labs Ltd₹ 21,47659.520.422.2
J B Chemicals & Pharmaceuticals Ltd₹ 22,76046.822.417.6
Ajanta Pharma Ltd₹ 23,83836.117.922.6
Natco Pharma Ltd₹ 13,94512.415.317.7
ERIS Lifesciences Ltd₹ 12,05431.918.016.7
Indoco Remedies Ltd₹ 3,77033.314.817.4
Suven Pharmaceuticals Ltd₹ 17,55440.624.532.5

Product & Services

source: official website

  1. Cephalosporins: Antibiotics belonging to the cephalosporin class, used to treat bacterial infections.
  2. Proton Pump Inhibitor: Medications that reduce stomach acid production, commonly used to treat acid-related conditions.
  3. Anticholinergic and Heparin NSAIDs: Medications with anticholinergic properties, heparin (an anticoagulant), and nonsteroidal anti-inflammatory drugs (NSAIDs).
  4. Analgesics and Antipyretic: Pain relievers and fever-reducing medications.
  5. Anticold and Antiallergic: Medications to relieve symptoms associated with the common cold and allergies.
  6. Antiemetic: Drugs that prevent or alleviate nausea and vomiting.
  7. Antidiabetic: Medications used to manage diabetes.
  8. Antispasmodic: Drugs that relieve muscle spasms.
  9. Antifibrinolytic: Medications that prevent the breakdown of blood clots.
  10. Cardiovascular: Medications related to heart health and blood vessels.
  11. Antioxidant and Vitamins: Supplements with antioxidant properties and essential vitamins.
  12. Antihyperuricemia and Antigout: Medications for managing conditions like gout and high uric acid levels.
  13. Fluoroquinolone and Macrolide: Antibiotics from different classes used to treat bacterial infections.
  14. Nootropics and Neurotonics / Neurotrophics: Drugs that enhance cognitive function and support nerve health.
  15. Antiulcerative: Medications to treat and prevent ulcers.
  16. Antimalarial Anxiolytic: Medications for malaria treatment and anxiety relief.
  17. Anticonvulsant and Antipsychotic: Drugs used to control seizures and manage psychiatric conditions.
  18. Bladder and Prostate Disorder: Medications for conditions affecting the bladder and prostate.
  19. Antifungal, Anthelmintic, and Antiviral Anticholinergic: Medications for fungal, parasitic, and viral infections.
  20. Anti-Asthmatic and Bronchodilator: Medications for asthma and bronchial conditions.


source: official website

Other Current And Upcoming IPOs


When is Innova Captab Listing date?

The Innova Captab IPO listing date is not yet announced. The tentative date of Innova Captab IPO listing is Friday, December 29, 2023.

What is the Lot Size of Innova Captab?

Innova Captab IPO lot size is 33 Shares, and the minimum amount required is ₹14,784.

When Innova Captab Will Open?

The Innova Captab IPO opens on December 21, 2023 and closes on December 26, 2023.


The information presented is for general informational purposes only. We make no representations or warranties of any kind regarding accuracy or completeness. Any reliance on this information is at your own risk. We disclaim liability for any loss or damage, direct or indirect, arising from use of this content. External links are provided for convenience, but we do not endorse or guarantee their content. Content is subject to change without notice. It is advisable to seek professional advice and conduct independent research before making any decisions based on the information provided.